Divi's Laboratories Limited
DIVISLAB
Rank in Stocks
#903
Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India,... Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India, operates globally in the production and distribution of generic active pharmaceutical ingredients (APIs), intermediate chemicals, and nutraceuticals. The company's market footprint encompasses India, the United States, Asia, Europe, and other international regions. In addition to its core product lines, Divi's offers bespoke synthesis services for APIs and intermediates. It also provides a diverse range of carotenoids and markets various vitamins, catering to the nutritional, pharmaceutical, food and beverage, and animal feed industries. The firm was formerly known as Divi's Research Center before rebranding to Divi's Laboratories Limited in 1994.
Share Price
$100.25
Last synced: 2026-10-19
Market Cap
$26.61B
Change (1 day)
-0.44%
Change (1 year)
33.40%
Country
IN
Trade Divi's Laboratories Limited (DIVISLAB)
Category
Healthcare
P/E ratio for Divi's Laboratories Limited (DIVISLAB)
P/E ratio as of October 2026 TTM: 82.25
According to Divi's Laboratories Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 82.25. At the end of 2024 the company had a P/E ratio of 59.20.
P/E ratio history for Divi's Laboratories Limited from 2005 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 82.25 | 22.33% |
| 2025 | 67.24 | 13.59% |
| 2024 | 59.20 | 44.07% |
| 2023 | 41.09 | 4.10% |
| 2022 | 39.47 | -18.56% |
| 2021 | 48.47 | 26.35% |
| 2020 | 38.36 | 13.43% |
| 2019 | 33.82 | 2.47% |
| 2018 | 33.00 | 111.33% |
| 2017 | 15.62 | -32.91% |
| 2016 | 23.28 | -16.35% |
| 2015 | 27.83 | 18.72% |
| 2014 | 23.44 | 6.49% |
| 2013 | 22.02 | 15.52% |
| 2012 | 19.06 | -8.46% |
| 2011 | 20.82 | -19.87% |
| 2010 | 25.98 | 77.15% |
| 2009 | 14.67 | -37.76% |
| 2008 | 23.57 | 11.09% |
| 2007 | 21.21 | -38.67% |
| 2006 | 34.59 | 78.78% |
| 2005 | 19.35 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 34.96 | -57.50% |
IN
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.